Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome

Haematologica

Volumn 85, Issue 11, 2000, Pages 1224-1225

  Abdel Raheem, M M ^a   Jamil, M G ^a   Potti, A ^a   Gross, G G ^a  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

CLL; Fludarabine; Nephrotic syndrome

Indexed keywords

FLUDARABINE;

ADULT; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; NEPHROTIC SYNDROME; PROTEINURIA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINURIA; REMISSION INDUCTION; TREATMENT OUTCOME; VIDARABINE;

EID: 0033658677     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. A review of nephroric syndrome associated with chronic lymphocytic leukemia
2. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas
3. Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders
4. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy
5. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy
6. Chronic lymphocytic leukemia-associated membranous glomerulopathy: Remission with fludarabine